What oral contraception is recommended for breastfeeding women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Contraception for Breastfeeding Women

Progestin-only pills (POPs) are the recommended oral contraceptive for breastfeeding mothers and can be started immediately postpartum, while combined hormonal contraceptives containing estrogen should be avoided during the first 6 weeks and generally not used until after 6 months of breastfeeding. 1, 2

Progestin-Only Pills: The Preferred Choice

POPs are safe for immediate postpartum initiation and do not adversely affect milk production or infant growth. 1, 2

Timing and Backup Contraception Requirements

  • No backup contraception is needed if POPs are started within 6 months postpartum while the mother is amenorrheic and fully or nearly fully breastfeeding (≥85% of feeds are breastfeeds). 1, 2

  • If started >21 days postpartum without return of menses, use backup contraception for 7 days. 1, 2

  • POPs can be initiated within days of delivery with adequate data showing no detrimental effects on lactation or infant health. 3

Evidence Supporting Safety

  • Multiple trials demonstrate no significant differences in breastfeeding duration, breast milk composition, or infant growth with POP use. 4

  • Progestin-only methods do not appear to affect milk volume or composition and cause no deleterious effects in infants. 3, 5

  • Steroids transfer from plasma into milk in very small quantities, typically too low to detect in infants, and theoretical concerns about effects on neonatal reproductive development are unwarranted. 5

Combined Hormonal Contraceptives: Avoid During Breastfeeding

Combined oral contraceptives containing estrogen should not be used during breastfeeding, particularly in the first 6 months postpartum. 1, 2, 6

Timing Restrictions Based on Risk Categories

  • <3 weeks postpartum: Absolutely contraindicated (U.S. MEC Category 4) due to increased venous thromboembolism (VTE) risk. 1, 2, 7

  • 4 weeks to 6 months postpartum: Generally not recommended (U.S. MEC Category 3) due to potential negative effects on breastfeeding performance and milk production. 1, 2

  • After 6 months postpartum: CHCs may be considered if milk supply is well-established and supplementation is available, though POPs remain preferred. 2

Risks of Combined Hormonal Contraceptives

  • Estrogen-containing contraceptives can reduce milk production, with older studies showing lower milk volume compared to placebo (e.g., at 16 weeks: mean difference -24.00 mL, 95% CI -34.53 to -13.47). 4

  • Additional VTE risk factors make CHCs inadvisable at 4-6 weeks postpartum. 1, 2

  • Reduced milk supply can lead to earlier discontinuation of contraception and potential unintended pregnancy if supplementation is inadequate. 3

If a Woman Insists on CHCs

Wait a minimum of 6 weeks postpartum, ensure no additional VTE risk factors exist, and confirm access to supplemental milk. 1, 2

Special Population: Prior Gestational Diabetes

  • In women with prior gestational diabetes, particularly in Latino populations, use progestin-only oral contraceptives with caution due to a two- to threefold increase in diabetes risk. 2

  • Consider discussing non-hormonal alternatives in this population. 2

Clinical Algorithm for Selection

  1. First 3 weeks postpartum: POPs only (CHCs are Category 4—unacceptable health risk). 1, 2

  2. 3 weeks to 6 months postpartum: POPs strongly preferred (CHCs are Category 3—risks usually outweigh benefits). 1, 2

  3. After 6 months postpartum: POPs remain preferred, but CHCs may be considered if milk supply is well-established and supplementation is available. 2

  4. Special consideration: In women with prior gestational diabetes, particularly in Latino populations, discuss increased diabetes risk with progestin-only methods and consider non-hormonal alternatives. 2

Common Pitfalls to Avoid

  • Do not delay contraception counseling until the 6-week postpartum visit, as many women do not return for follow-up and immediate postpartum contact provides an optimal opportunity for contraceptive initiation. 3, 8

  • Do not prescribe CHCs to breastfeeding women without adequate access to supplemental milk, as decreased milk volume can lead to contraceptive discontinuation and unintended pregnancy. 3

  • Do not assume all hormonal contraceptives affect lactation equally—the evidence clearly distinguishes between progestin-only methods (safe) and combined methods (problematic during early breastfeeding). 8, 4

References

Guideline

Oral Contraceptives During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Contraception Guidance for Breastfeeding Mothers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hormonal contraception and lactation.

Journal of human lactation : official journal of International Lactation Consultant Association, 1996

Guideline

Contraception and Breastfeeding Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Breastfeeding and Hormonal Contraception: A Scoping Review of Clinical Guidelines, Professional Association Recommendations, and the Literature.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.